COVID-19 has recently emerged as an age-related disease whose mechanisms are still poorly understood. Using a combination of hypothesis-oriented and unsupervised, data-driven approaches, as well as patients and pre-clinical models, we expect to come up with candidate proteins and pathways which could not only predict the susceptibility to the disease, but also unveil the molecular mechanisms through which aging contributes to SARS-Cov-2 infection. We also expect to provide candidate FDA and ANVISA approved drugs which could potentially target these pathways to prevent, mitigate or eliminate virus infection. Our overarching aim is to elucidate how aging constitutes the main risk factor for COVID-19, providing potential solutions to its pandemic. (AU)
Articles published in Agência FAPESP Newsletter about the research grant:
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
PASCOAL, LIVIA BITENCOURT;
RODRIGUES, PATRICIA BRITO;
GENARO, LIVIA MOREIRA;
DOS SANTOS PEREIRA GOMES, ARILSON BERNARDO;
TOLEDO-TEIXEIRA, DANIEL AUGUSTO;
PARISE, PIERINA LORENCINI;
SIMEONI, CAMILA LOPES;
GUIMARAES, PAULA VERI;
BUSCARATTI, LUCAS ILDEFONSO;
DE ANGELI ELSTON, JOAO GABRIEL;
SETSUKO AYRIZONO, MARIA DE LOURDES;
VELLOSO, LICIO AUGUSTO;
PROENCA-MODENA, JOSE LUIZ;
MENDES MORAES-VIEIRA, PEDRO MANOEL;
SILVA MORI, MARCELO ALVES;
FARIAS, ALESSANDRO SANTOS;
RAMIREZ VINOLO, MARCO AURELIO;
LEAL, RAQUEL FRANCO.
Microbiota-derived short-chain fatty acids do not interfere with SARS-CoV-2 infection of human colonic samples.
JAN 1 2021.
Web of Science Citations: 0.
Please report errors in scientific publications list by writing to: